nodes	percent_of_prediction	percent_of_DWPC	metapath
Treprostinil—PTGIR—Prostanoid ligand receptors—PTGER4—ankylosing spondylitis	0.0111	0.291	CbGpPWpGaD
Treprostinil—PTGIR—Eicosanoid ligand-binding receptors—PTGER4—ankylosing spondylitis	0.00739	0.193	CbGpPWpGaD
Treprostinil—PTGIR—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.00612	0.16	CbGpPWpGaD
Treprostinil—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00452	0.00469	CcSEcCtD
Treprostinil—Haemoglobin—Triamcinolone—ankylosing spondylitis	0.00447	0.00465	CcSEcCtD
Treprostinil—Haemoglobin—Methylprednisolone—ankylosing spondylitis	0.00446	0.00464	CcSEcCtD
Treprostinil—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00446	0.00463	CcSEcCtD
Treprostinil—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00445	0.00462	CcSEcCtD
Treprostinil—Haemorrhage—Triamcinolone—ankylosing spondylitis	0.00445	0.00462	CcSEcCtD
Treprostinil—Haemorrhage—Methylprednisolone—ankylosing spondylitis	0.00444	0.00461	CcSEcCtD
Treprostinil—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00441	0.00459	CcSEcCtD
Treprostinil—PTGIR—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.00424	0.111	CbGpPWpGaD
Treprostinil—Erythema—Prednisolone—ankylosing spondylitis	0.00421	0.00438	CcSEcCtD
Treprostinil—Bradycardia—Betamethasone—ankylosing spondylitis	0.00411	0.00427	CcSEcCtD
Treprostinil—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00411	0.00427	CcSEcCtD
Treprostinil—Haemoglobin—Dexamethasone—ankylosing spondylitis	0.00405	0.00422	CcSEcCtD
Treprostinil—Haemoglobin—Betamethasone—ankylosing spondylitis	0.00405	0.00422	CcSEcCtD
Treprostinil—Haemorrhage—Betamethasone—ankylosing spondylitis	0.00403	0.00419	CcSEcCtD
Treprostinil—Haemorrhage—Dexamethasone—ankylosing spondylitis	0.00403	0.00419	CcSEcCtD
Treprostinil—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.0039	0.00406	CcSEcCtD
Treprostinil—Depression—Prednisone—ankylosing spondylitis	0.0039	0.00406	CcSEcCtD
Treprostinil—Erythema—Triamcinolone—ankylosing spondylitis	0.00387	0.00402	CcSEcCtD
Treprostinil—Erythema—Methylprednisolone—ankylosing spondylitis	0.00386	0.00401	CcSEcCtD
Treprostinil—Angioedema—Prednisolone—ankylosing spondylitis	0.00384	0.004	CcSEcCtD
Treprostinil—Malaise—Prednisolone—ankylosing spondylitis	0.00379	0.00395	CcSEcCtD
Treprostinil—Syncope—Prednisolone—ankylosing spondylitis	0.00377	0.00392	CcSEcCtD
Treprostinil—Back pain—Triamcinolone—ankylosing spondylitis	0.00374	0.00389	CcSEcCtD
Treprostinil—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.0037	0.00385	CcSEcCtD
Treprostinil—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00359	0.00373	CcSEcCtD
Treprostinil—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.00358	0.00372	CcSEcCtD
Treprostinil—Bradycardia—Prednisone—ankylosing spondylitis	0.00358	0.00372	CcSEcCtD
Treprostinil—Discomfort—Prednisolone—ankylosing spondylitis	0.00354	0.00368	CcSEcCtD
Treprostinil—Angioedema—Triamcinolone—ankylosing spondylitis	0.00354	0.00368	CcSEcCtD
Treprostinil—Haemoglobin—Prednisone—ankylosing spondylitis	0.00353	0.00367	CcSEcCtD
Treprostinil—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00353	0.00367	CcSEcCtD
Treprostinil—Abdominal discomfort—Methotrexate—ankylosing spondylitis	0.00352	0.00366	CcSEcCtD
Treprostinil—Haemorrhage—Prednisone—ankylosing spondylitis	0.00351	0.00365	CcSEcCtD
Treprostinil—Erythema—Dexamethasone—ankylosing spondylitis	0.00351	0.00365	CcSEcCtD
Treprostinil—Erythema—Betamethasone—ankylosing spondylitis	0.00351	0.00365	CcSEcCtD
Treprostinil—Malaise—Triamcinolone—ankylosing spondylitis	0.00349	0.00363	CcSEcCtD
Treprostinil—Malaise—Methylprednisolone—ankylosing spondylitis	0.00348	0.00362	CcSEcCtD
Treprostinil—Syncope—Triamcinolone—ankylosing spondylitis	0.00347	0.00361	CcSEcCtD
Treprostinil—Syncope—Methylprednisolone—ankylosing spondylitis	0.00346	0.0036	CcSEcCtD
Treprostinil—Oedema—Prednisolone—ankylosing spondylitis	0.00343	0.00357	CcSEcCtD
Treprostinil—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.0034	0.00354	CcSEcCtD
Treprostinil—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00339	0.00353	CcSEcCtD
Treprostinil—Shock—Prednisolone—ankylosing spondylitis	0.00338	0.00351	CcSEcCtD
Treprostinil—Cough—Triamcinolone—ankylosing spondylitis	0.00338	0.00351	CcSEcCtD
Treprostinil—Tachycardia—Prednisolone—ankylosing spondylitis	0.00335	0.00349	CcSEcCtD
Treprostinil—Myalgia—Triamcinolone—ankylosing spondylitis	0.00329	0.00343	CcSEcCtD
Treprostinil—Pneumonia—Methotrexate—ankylosing spondylitis	0.00329	0.00342	CcSEcCtD
Treprostinil—Myalgia—Methylprednisolone—ankylosing spondylitis	0.00329	0.00342	CcSEcCtD
Treprostinil—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.00329	0.00342	CcSEcCtD
Treprostinil—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00328	0.00341	CcSEcCtD
Treprostinil—Depression—Methotrexate—ankylosing spondylitis	0.00326	0.00339	CcSEcCtD
Treprostinil—Flushing—Prednisone—ankylosing spondylitis	0.00326	0.00339	CcSEcCtD
Treprostinil—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.00326	0.00339	CcSEcCtD
Treprostinil—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.00326	0.00339	CcSEcCtD
Treprostinil—Discomfort—Triamcinolone—ankylosing spondylitis	0.00325	0.00338	CcSEcCtD
Treprostinil—Discomfort—Methylprednisolone—ankylosing spondylitis	0.00325	0.00338	CcSEcCtD
Treprostinil—Angioedema—Betamethasone—ankylosing spondylitis	0.00321	0.00334	CcSEcCtD
Treprostinil—Angioedema—Dexamethasone—ankylosing spondylitis	0.00321	0.00334	CcSEcCtD
Treprostinil—Malaise—Dexamethasone—ankylosing spondylitis	0.00317	0.00329	CcSEcCtD
Treprostinil—Malaise—Betamethasone—ankylosing spondylitis	0.00317	0.00329	CcSEcCtD
Treprostinil—Oedema—Triamcinolone—ankylosing spondylitis	0.00316	0.00328	CcSEcCtD
Treprostinil—Syncope—Betamethasone—ankylosing spondylitis	0.00315	0.00327	CcSEcCtD
Treprostinil—Syncope—Dexamethasone—ankylosing spondylitis	0.00315	0.00327	CcSEcCtD
Treprostinil—Infection—Triamcinolone—ankylosing spondylitis	0.00314	0.00326	CcSEcCtD
Treprostinil—Infection—Methylprednisolone—ankylosing spondylitis	0.00313	0.00326	CcSEcCtD
Treprostinil—Haematuria—Methotrexate—ankylosing spondylitis	0.00312	0.00324	CcSEcCtD
Treprostinil—Shock—Triamcinolone—ankylosing spondylitis	0.00311	0.00323	CcSEcCtD
Treprostinil—Insomnia—Prednisolone—ankylosing spondylitis	0.00311	0.00323	CcSEcCtD
Treprostinil—Shock—Methylprednisolone—ankylosing spondylitis	0.0031	0.00322	CcSEcCtD
Treprostinil—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00309	0.00321	CcSEcCtD
Treprostinil—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00309	0.00321	CcSEcCtD
Treprostinil—Epistaxis—Methotrexate—ankylosing spondylitis	0.00308	0.00321	CcSEcCtD
Treprostinil—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00308	0.00321	CcSEcCtD
Treprostinil—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00308	0.0032	CcSEcCtD
Treprostinil—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00308	0.0032	CcSEcCtD
Treprostinil—Erythema—Prednisone—ankylosing spondylitis	0.00306	0.00318	CcSEcCtD
Treprostinil—Myalgia—Betamethasone—ankylosing spondylitis	0.00299	0.00311	CcSEcCtD
Treprostinil—Myalgia—Dexamethasone—ankylosing spondylitis	0.00299	0.00311	CcSEcCtD
Treprostinil—Anxiety—Betamethasone—ankylosing spondylitis	0.00298	0.0031	CcSEcCtD
Treprostinil—Anxiety—Dexamethasone—ankylosing spondylitis	0.00298	0.0031	CcSEcCtD
Treprostinil—Discomfort—Dexamethasone—ankylosing spondylitis	0.00295	0.00307	CcSEcCtD
Treprostinil—Discomfort—Betamethasone—ankylosing spondylitis	0.00295	0.00307	CcSEcCtD
Treprostinil—Haemoglobin—Methotrexate—ankylosing spondylitis	0.00295	0.00307	CcSEcCtD
Treprostinil—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00294	0.00306	CcSEcCtD
Treprostinil—Pain—Prednisolone—ankylosing spondylitis	0.00294	0.00305	CcSEcCtD
Treprostinil—Haemorrhage—Methotrexate—ankylosing spondylitis	0.00294	0.00305	CcSEcCtD
Treprostinil—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00291	0.00303	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00288	0.00299	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00287	0.00299	CcSEcCtD
Treprostinil—Oedema—Betamethasone—ankylosing spondylitis	0.00287	0.00298	CcSEcCtD
Treprostinil—Oedema—Dexamethasone—ankylosing spondylitis	0.00287	0.00298	CcSEcCtD
Treprostinil—Insomnia—Triamcinolone—ankylosing spondylitis	0.00286	0.00297	CcSEcCtD
Treprostinil—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00285	0.00296	CcSEcCtD
Treprostinil—Infection—Betamethasone—ankylosing spondylitis	0.00285	0.00296	CcSEcCtD
Treprostinil—Infection—Dexamethasone—ankylosing spondylitis	0.00285	0.00296	CcSEcCtD
Treprostinil—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.00284	0.00295	CcSEcCtD
Treprostinil—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00284	0.00295	CcSEcCtD
Treprostinil—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00283	0.00294	CcSEcCtD
Treprostinil—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00283	0.00294	CcSEcCtD
Treprostinil—Anaemia—Prednisone—ankylosing spondylitis	0.00283	0.00294	CcSEcCtD
Treprostinil—Shock—Betamethasone—ankylosing spondylitis	0.00282	0.00293	CcSEcCtD
Treprostinil—Shock—Dexamethasone—ankylosing spondylitis	0.00282	0.00293	CcSEcCtD
Treprostinil—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00282	0.00293	CcSEcCtD
Treprostinil—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00281	0.00292	CcSEcCtD
Treprostinil—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00281	0.00292	CcSEcCtD
Treprostinil—Tachycardia—Dexamethasone—ankylosing spondylitis	0.0028	0.00291	CcSEcCtD
Treprostinil—Tachycardia—Betamethasone—ankylosing spondylitis	0.0028	0.00291	CcSEcCtD
Treprostinil—Angioedema—Prednisone—ankylosing spondylitis	0.00279	0.00291	CcSEcCtD
Treprostinil—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00278	0.00289	CcSEcCtD
Treprostinil—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00277	0.00288	CcSEcCtD
Treprostinil—Malaise—Prednisone—ankylosing spondylitis	0.00276	0.00287	CcSEcCtD
Treprostinil—Syncope—Prednisone—ankylosing spondylitis	0.00274	0.00285	CcSEcCtD
Treprostinil—Anorexia—Dexamethasone—ankylosing spondylitis	0.00273	0.00284	CcSEcCtD
Treprostinil—Anorexia—Betamethasone—ankylosing spondylitis	0.00273	0.00284	CcSEcCtD
Treprostinil—Fatigue—Triamcinolone—ankylosing spondylitis	0.00272	0.00283	CcSEcCtD
Treprostinil—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00272	0.00282	CcSEcCtD
Treprostinil—Pain—Triamcinolone—ankylosing spondylitis	0.0027	0.00281	CcSEcCtD
Treprostinil—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00269	0.00279	CcSEcCtD
Treprostinil—Hypotension—Betamethasone—ankylosing spondylitis	0.00268	0.00278	CcSEcCtD
Treprostinil—Hypotension—Dexamethasone—ankylosing spondylitis	0.00268	0.00278	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00261	0.00271	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00261	0.00271	CcSEcCtD
Treprostinil—Arthralgia—Prednisone—ankylosing spondylitis	0.0026	0.00271	CcSEcCtD
Treprostinil—Myalgia—Prednisone—ankylosing spondylitis	0.0026	0.00271	CcSEcCtD
Treprostinil—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.0026	0.00271	CcSEcCtD
Treprostinil—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.0026	0.0027	CcSEcCtD
Treprostinil—Anxiety—Prednisone—ankylosing spondylitis	0.00259	0.0027	CcSEcCtD
Treprostinil—Insomnia—Dexamethasone—ankylosing spondylitis	0.00259	0.00269	CcSEcCtD
Treprostinil—Insomnia—Betamethasone—ankylosing spondylitis	0.00259	0.00269	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00258	0.00268	CcSEcCtD
Treprostinil—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00257	0.00268	CcSEcCtD
Treprostinil—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00257	0.00268	CcSEcCtD
Treprostinil—Discomfort—Prednisone—ankylosing spondylitis	0.00257	0.00267	CcSEcCtD
Treprostinil—Erythema—Methotrexate—ankylosing spondylitis	0.00256	0.00266	CcSEcCtD
Treprostinil—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00252	0.00262	CcSEcCtD
Treprostinil—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00252	0.00262	CcSEcCtD
Treprostinil—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.0025	0.0026	CcSEcCtD
Treprostinil—Oedema—Prednisone—ankylosing spondylitis	0.0025	0.00259	CcSEcCtD
Treprostinil—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00249	0.00259	CcSEcCtD
Treprostinil—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00249	0.00259	CcSEcCtD
Treprostinil—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00249	0.00259	CcSEcCtD
Treprostinil—Infection—Prednisone—ankylosing spondylitis	0.00248	0.00258	CcSEcCtD
Treprostinil—Back pain—Methotrexate—ankylosing spondylitis	0.00247	0.00257	CcSEcCtD
Treprostinil—Fatigue—Dexamethasone—ankylosing spondylitis	0.00247	0.00257	CcSEcCtD
Treprostinil—Fatigue—Betamethasone—ankylosing spondylitis	0.00247	0.00257	CcSEcCtD
Treprostinil—Shock—Prednisone—ankylosing spondylitis	0.00246	0.00255	CcSEcCtD
Treprostinil—Pain—Betamethasone—ankylosing spondylitis	0.00245	0.00255	CcSEcCtD
Treprostinil—Pain—Dexamethasone—ankylosing spondylitis	0.00245	0.00255	CcSEcCtD
Treprostinil—Tachycardia—Prednisone—ankylosing spondylitis	0.00244	0.00253	CcSEcCtD
Treprostinil—Anorexia—Prednisone—ankylosing spondylitis	0.00238	0.00247	CcSEcCtD
Treprostinil—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00237	0.00247	CcSEcCtD
Treprostinil—Anaemia—Methotrexate—ankylosing spondylitis	0.00236	0.00246	CcSEcCtD
Treprostinil—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00236	0.00246	CcSEcCtD
Treprostinil—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00236	0.00246	CcSEcCtD
Treprostinil—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00234	0.00244	CcSEcCtD
Treprostinil—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00234	0.00244	CcSEcCtD
Treprostinil—Malaise—Methotrexate—ankylosing spondylitis	0.0023	0.0024	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00227	0.00236	CcSEcCtD
Treprostinil—Dizziness—Prednisolone—ankylosing spondylitis	0.00227	0.00236	CcSEcCtD
Treprostinil—Asthenia—Triamcinolone—ankylosing spondylitis	0.00227	0.00236	CcSEcCtD
Treprostinil—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00227	0.00236	CcSEcCtD
Treprostinil—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00227	0.00236	CcSEcCtD
Treprostinil—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00227	0.00236	CcSEcCtD
Treprostinil—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00227	0.00236	CcSEcCtD
Treprostinil—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00226	0.00235	CcSEcCtD
Treprostinil—Insomnia—Prednisone—ankylosing spondylitis	0.00226	0.00235	CcSEcCtD
Treprostinil—Paraesthesia—Prednisone—ankylosing spondylitis	0.00224	0.00233	CcSEcCtD
Treprostinil—Pruritus—Triamcinolone—ankylosing spondylitis	0.00223	0.00232	CcSEcCtD
Treprostinil—Cough—Methotrexate—ankylosing spondylitis	0.00223	0.00232	CcSEcCtD
Treprostinil—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00223	0.00232	CcSEcCtD
Treprostinil—Dyspepsia—Prednisone—ankylosing spondylitis	0.0022	0.00228	CcSEcCtD
Treprostinil—Arthralgia—Methotrexate—ankylosing spondylitis	0.00218	0.00226	CcSEcCtD
Treprostinil—Chest pain—Methotrexate—ankylosing spondylitis	0.00218	0.00226	CcSEcCtD
Treprostinil—Myalgia—Methotrexate—ankylosing spondylitis	0.00218	0.00226	CcSEcCtD
Treprostinil—Decreased appetite—Prednisone—ankylosing spondylitis	0.00217	0.00226	CcSEcCtD
Treprostinil—Rash—Prednisolone—ankylosing spondylitis	0.00217	0.00225	CcSEcCtD
Treprostinil—Dermatitis—Prednisolone—ankylosing spondylitis	0.00216	0.00225	CcSEcCtD
Treprostinil—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00216	0.00224	CcSEcCtD
Treprostinil—Fatigue—Prednisone—ankylosing spondylitis	0.00215	0.00224	CcSEcCtD
Treprostinil—Headache—Prednisolone—ankylosing spondylitis	0.00215	0.00224	CcSEcCtD
Treprostinil—Discomfort—Methotrexate—ankylosing spondylitis	0.00215	0.00224	CcSEcCtD
Treprostinil—Dizziness—Triamcinolone—ankylosing spondylitis	0.00209	0.00217	CcSEcCtD
Treprostinil—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00208	0.00217	CcSEcCtD
Treprostinil—Infection—Methotrexate—ankylosing spondylitis	0.00207	0.00215	CcSEcCtD
Treprostinil—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00206	0.00214	CcSEcCtD
Treprostinil—Asthenia—Betamethasone—ankylosing spondylitis	0.00206	0.00214	CcSEcCtD
Treprostinil—Asthenia—Dexamethasone—ankylosing spondylitis	0.00206	0.00214	CcSEcCtD
Treprostinil—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.00204	0.00212	CcSEcCtD
Treprostinil—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00204	0.00212	CcSEcCtD
Treprostinil—Nausea—Prednisolone—ankylosing spondylitis	0.00204	0.00212	CcSEcCtD
Treprostinil—Pruritus—Dexamethasone—ankylosing spondylitis	0.00203	0.00211	CcSEcCtD
Treprostinil—Pruritus—Betamethasone—ankylosing spondylitis	0.00203	0.00211	CcSEcCtD
Treprostinil—Vomiting—Triamcinolone—ankylosing spondylitis	0.00201	0.00209	CcSEcCtD
Treprostinil—Vomiting—Methylprednisolone—ankylosing spondylitis	0.002	0.00208	CcSEcCtD
Treprostinil—Rash—Triamcinolone—ankylosing spondylitis	0.00199	0.00207	CcSEcCtD
Treprostinil—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00199	0.00207	CcSEcCtD
Treprostinil—Anorexia—Methotrexate—ankylosing spondylitis	0.00199	0.00207	CcSEcCtD
Treprostinil—Rash—Methylprednisolone—ankylosing spondylitis	0.00199	0.00207	CcSEcCtD
Treprostinil—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00198	0.00206	CcSEcCtD
Treprostinil—Headache—Triamcinolone—ankylosing spondylitis	0.00198	0.00206	CcSEcCtD
Treprostinil—Headache—Methylprednisolone—ankylosing spondylitis	0.00197	0.00205	CcSEcCtD
Treprostinil—Abdominal pain—Prednisone—ankylosing spondylitis	0.00197	0.00205	CcSEcCtD
Treprostinil—Body temperature increased—Prednisone—ankylosing spondylitis	0.00197	0.00205	CcSEcCtD
Treprostinil—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00196	0.00204	CcSEcCtD
Treprostinil—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00196	0.00204	CcSEcCtD
Treprostinil—Hypotension—Methotrexate—ankylosing spondylitis	0.00195	0.00203	CcSEcCtD
Treprostinil—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.0019	0.00198	CcSEcCtD
Treprostinil—Dizziness—Betamethasone—ankylosing spondylitis	0.00189	0.00197	CcSEcCtD
Treprostinil—Dizziness—Dexamethasone—ankylosing spondylitis	0.00189	0.00197	CcSEcCtD
Treprostinil—Insomnia—Methotrexate—ankylosing spondylitis	0.00189	0.00196	CcSEcCtD
Treprostinil—Nausea—Triamcinolone—ankylosing spondylitis	0.00188	0.00195	CcSEcCtD
Treprostinil—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00187	0.00195	CcSEcCtD
Treprostinil—Nausea—Methylprednisolone—ankylosing spondylitis	0.00187	0.00195	CcSEcCtD
Treprostinil—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00186	0.00193	CcSEcCtD
Treprostinil—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00184	0.00191	CcSEcCtD
Treprostinil—Vomiting—Dexamethasone—ankylosing spondylitis	0.00182	0.00189	CcSEcCtD
Treprostinil—Vomiting—Betamethasone—ankylosing spondylitis	0.00182	0.00189	CcSEcCtD
Treprostinil—Decreased appetite—Methotrexate—ankylosing spondylitis	0.00181	0.00189	CcSEcCtD
Treprostinil—Rash—Betamethasone—ankylosing spondylitis	0.00181	0.00188	CcSEcCtD
Treprostinil—Rash—Dexamethasone—ankylosing spondylitis	0.00181	0.00188	CcSEcCtD
Treprostinil—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00181	0.00188	CcSEcCtD
Treprostinil—Dermatitis—Betamethasone—ankylosing spondylitis	0.00181	0.00188	CcSEcCtD
Treprostinil—Fatigue—Methotrexate—ankylosing spondylitis	0.0018	0.00187	CcSEcCtD
Treprostinil—Headache—Dexamethasone—ankylosing spondylitis	0.0018	0.00187	CcSEcCtD
Treprostinil—Headache—Betamethasone—ankylosing spondylitis	0.0018	0.00187	CcSEcCtD
Treprostinil—Asthenia—Prednisone—ankylosing spondylitis	0.00179	0.00186	CcSEcCtD
Treprostinil—Pain—Methotrexate—ankylosing spondylitis	0.00178	0.00185	CcSEcCtD
Treprostinil—Pruritus—Prednisone—ankylosing spondylitis	0.00177	0.00184	CcSEcCtD
Treprostinil—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00172	0.00179	CcSEcCtD
Treprostinil—Diarrhoea—Prednisone—ankylosing spondylitis	0.00171	0.00178	CcSEcCtD
Treprostinil—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00171	0.00177	CcSEcCtD
Treprostinil—Nausea—Dexamethasone—ankylosing spondylitis	0.0017	0.00177	CcSEcCtD
Treprostinil—Nausea—Betamethasone—ankylosing spondylitis	0.0017	0.00177	CcSEcCtD
Treprostinil—Dizziness—Prednisone—ankylosing spondylitis	0.00165	0.00172	CcSEcCtD
Treprostinil—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00165	0.00171	CcSEcCtD
Treprostinil—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00165	0.00171	CcSEcCtD
Treprostinil—Vomiting—Prednisone—ankylosing spondylitis	0.00159	0.00165	CcSEcCtD
Treprostinil—Rash—Prednisone—ankylosing spondylitis	0.00157	0.00164	CcSEcCtD
Treprostinil—Dermatitis—Prednisone—ankylosing spondylitis	0.00157	0.00163	CcSEcCtD
Treprostinil—Headache—Prednisone—ankylosing spondylitis	0.00156	0.00163	CcSEcCtD
Treprostinil—Asthenia—Methotrexate—ankylosing spondylitis	0.0015	0.00156	CcSEcCtD
Treprostinil—Nausea—Prednisone—ankylosing spondylitis	0.00148	0.00154	CcSEcCtD
Treprostinil—Pruritus—Methotrexate—ankylosing spondylitis	0.00148	0.00153	CcSEcCtD
Treprostinil—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00143	0.00148	CcSEcCtD
Treprostinil—Dizziness—Methotrexate—ankylosing spondylitis	0.00138	0.00143	CcSEcCtD
Treprostinil—PTGIR—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00136	0.0356	CbGpPWpGaD
Treprostinil—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—ankylosing spondylitis	0.00133	0.0348	CbGpPWpGaD
Treprostinil—Vomiting—Methotrexate—ankylosing spondylitis	0.00133	0.00138	CcSEcCtD
Treprostinil—Rash—Methotrexate—ankylosing spondylitis	0.00131	0.00137	CcSEcCtD
Treprostinil—Dermatitis—Methotrexate—ankylosing spondylitis	0.00131	0.00137	CcSEcCtD
Treprostinil—Headache—Methotrexate—ankylosing spondylitis	0.00131	0.00136	CcSEcCtD
Treprostinil—Nausea—Methotrexate—ankylosing spondylitis	0.00124	0.00129	CcSEcCtD
Treprostinil—P2RY12—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000825	0.0215	CbGpPWpGaD
Treprostinil—PTGIR—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000759	0.0198	CbGpPWpGaD
Treprostinil—P2RY12—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000707	0.0185	CbGpPWpGaD
Treprostinil—PTGIR—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00065	0.017	CbGpPWpGaD
Treprostinil—P2RY12—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000538	0.0141	CbGpPWpGaD
Treprostinil—PTGIR—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000495	0.0129	CbGpPWpGaD
Treprostinil—PPARD—Adipogenesis—TNF—ankylosing spondylitis	0.000367	0.0096	CbGpPWpGaD
Treprostinil—P2RY12—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000304	0.00794	CbGpPWpGaD
Treprostinil—PPARD—Metabolism—B3GNT2—ankylosing spondylitis	0.000287	0.00751	CbGpPWpGaD
Treprostinil—PTGIR—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00028	0.00731	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000276	0.00721	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000254	0.00664	CbGpPWpGaD
Treprostinil—P2RY12—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000197	0.00514	CbGpPWpGaD
Treprostinil—PTGIR—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000181	0.00473	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000163	0.00426	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—PTGER4—ankylosing spondylitis	0.00015	0.00392	CbGpPWpGaD
Treprostinil—P2RY12—Signaling Pathways—MMP3—ankylosing spondylitis	0.000116	0.00303	CbGpPWpGaD
Treprostinil—PTGIR—Signaling Pathways—MMP3—ankylosing spondylitis	0.000107	0.00279	CbGpPWpGaD
Treprostinil—CYP2C9—Metabolism—B3GNT2—ankylosing spondylitis	5.78e-05	0.00151	CbGpPWpGaD
